✦ LIBER ✦

Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma

✍ Scribed by Yu-Chung Huang; Chia-Jen Liu; Chun-Yu Liu; Jih-Tung Pai; Ying-Chung Hong; Hao-Wei Teng; Liang-Tsai Hsiao; Ta-Chung Chao; Jyh-Pyng Gau; Jin-Hwang Liu; Hui-Chi Hsu; Tzeon-Jye Chiou; Po-Min Chen; Yuan-Bin Yu; Cheng-Hwai Tzeng

Publisher: Springer
Year: 2011
Tongue: English
Weight: 155 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-011-1268-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Absolute lymphocyte count at the time of

Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma

✍ Luis F. Porrata; Kay Ristow; Thomas M. Habermann; Thomas E. Witzig; David J. Inw 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Kacey O'Rourke; Kirk Morris; Glen A. Kennedy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Matthew Hellmann; Jeffrey A. Barnes; Peter Hammerman; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Reply to intravenous methotrexate as cen

Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Ephraim P. Hochberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

I read with great interest the article by Cooperberg and coworkers 1 studying survival rates in differently treated men with early prostate cancer. In this study, patients who underwent radical prostatectomy had a substantially decreased disease-specific mortality, particularly in the higher-risk gr